Cubist Pharmaceuticals, Inc. (CBST) Tops Q2 EPS by 4c

Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) reported Q2 EPS of $0.42, $0.04 better than the analyst estimate of $0.38. Revenue for the quarter came in at $258.8 million versus the consensus estimate of $254.93 million.

For earnings history and earnings-related data on Cubist Pharmaceuticals, Inc. (CBST) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• York Space Systems, Inc. (YSS) Reports Q2 Loss of $0.31 ; Offers Guidance
• CapsoVision (CV) Misses Q2 EPS by 4c
• Audioeye, Inc. (AEYE) Misses Q2 EPS by 28c; Offer Guidance